Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.
about
Informing DSM-5: biological boundaries between bipolar I disorder, schizoaffective disorder, and schizophreniaValproate for acute mood episodes in bipolar disorderOxcarbazepine for acute affective episodes in bipolar disorderOlanzapine in long-term treatment for bipolar disorderTopiramate for acute affective episodes in bipolar disorderOlanzapine in long-term treatment for bipolar disorderCellular plasticity cascades in the pathophysiology and treatment of bipolar disorderAripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literatureDifferential antidepressant-like response to lithium treatment between mouse strains: effects of sex, maternal care, and mixed genetic background.Depression-like episodes in mice harboring mtDNA deletions in paraventricular thalamusMedicating mood with maintenance in mind: bipolar depression pharmacotherapy.Neuroleptic discontinuation syndromes.Signalling pathways in the brain: cellular transduction of mood stabilisation in the treatment of manic-depressive illness.Therapeutic drug monitoring of psychotropic medications.Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse.Antipsychotics and breast-feeding: a review of the literature.Does 'rebound mania' occur after stopping carbamazepine? A pilot study.Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks.Emerging trends in the treatment of rapid cycling bipolar disorder: a selected review.Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications.Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials.Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder.Maintenance therapies in bipolar disorders.Lithium revisited.Lithium for maintenance treatment of mood disorders.Management of psychiatric disorders in patients infected with human immunodeficiency virus.Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.Antipsychotic Maintenance Treatment: Time to Rethink?Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder.Treatment non-adherence in affective disorders.Endophenotypes in bipolar disorder.Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for PsychopharmacologyManaging bipolar disorder during pregnancy: weighing the risks and benefits.Lithium for prevention of mood episodes in bipolar disorders: systematic review and meta-analysis.Women and bipolar disorder across the life spanAssessing patients' perception of self-care agency in psychiatric care.Medication-free Alternatives for Long-term Maintenance of Bipolar Disorder: A Case Series.Antidepressants in bipolar disorder: the case for caution.Solving the antidepressant efficacy question: effect sizes in major depressive disorderRelapse into mania or depression following lithium discontinuation: a 7-year follow-up.
P2860
Q21245294-C0072E13-9739-444E-B5ED-8F17CC5B6D8FQ22252976-38EE930F-524C-41A0-AD3E-665DE10F343EQ24234152-3E488D09-401D-4D6D-9FD2-F5D5C3B2E012Q24241099-1AD0C549-E4B6-425C-BC7A-CCD452AB8515Q24244960-5801502C-76D2-43B2-8414-4D6F0BB82AA7Q24250116-4E253C36-AF66-4562-843E-493B658AFB88Q28251880-006FBFEB-7300-4370-BEDA-89ED976C81A3Q28478032-B4D351FF-4090-48BB-8C8D-FBE7B98F90C3Q30433921-32186ACD-B911-4270-8B70-A8B66EF5E557Q30847548-2916171C-DC58-42DF-B8AA-9F347295BE39Q33470676-EC9B707F-B7B2-488A-AD50-24E4ADF1E6BFQ33538378-07E2E3EC-0503-438B-B94A-CCCD736AB36CQ33809252-1CCEE0AD-6990-416F-BB06-B9C581A45FA0Q33888577-669C65B6-5ABA-4096-8FC1-9E312E503BD4Q33996824-564A4196-625A-43D8-A947-D061F04306FBQ33999141-69DE0783-D3C4-477A-9452-16947BEB7A80Q34098803-43040819-7B0F-4FEA-8848-19360224532BQ34180376-EA1EC912-0289-4CEB-85D5-F248C4411F72Q34185305-6010159C-19C3-4C94-90BB-0D21B9909C2AQ34188583-75FEF765-44EC-407C-AD2B-8F4E5A977653Q34197988-62AD59FC-3E20-4FE0-A8E7-DE5DFB3BD154Q34267385-987EA07D-1107-45CF-B770-D49B5872120DQ34268760-3BBCC2F1-5C89-4BF6-BC5A-E1CC2838A79CQ34270519-82C7417B-6D98-49A8-B122-5AF316E5C65CQ34282031-6270C0AC-2694-4B65-98E7-20FE7EFA51C5Q34340984-46534D23-B217-43A4-88FF-83072CFC6C89Q34424267-F9EBD473-8E3E-4FA1-9AF9-C9FFE32251C8Q34488215-B8CD1AEA-7768-4AE4-9AD0-1A9E0361F1A6Q34547920-2E7DDA17-F7A2-495C-A2C7-284ECE13171CQ34592227-9798556E-CC95-4290-8E9C-94993ED537C6Q34626051-0DD5EF98-3DC8-47ED-85D9-A1115DB127CFQ34676317-F2C1621B-DF83-42B3-90B3-D94A4DB4AF56Q34708409-12A4D629-5716-4994-8836-B63C876859F4Q34744822-444558CF-B8A6-418D-8175-22AE84EEC1FAQ35022930-30A540A6-583E-4F6D-90BB-98551A8BB309Q35055365-C98B5170-CACB-46E0-8E96-C9DF205D5737Q35585186-33265741-E075-47E1-9985-A2B5D49B0545Q35592492-D2C7148E-60A0-4D67-A0E0-5745A4F543F3Q35624327-0696D2D7-390D-42D7-A2BA-83044A647C26Q35630088-F8FB3F2F-E865-412D-B40A-329EEC0EADF4
P2860
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.
@en
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.
@nl
type
label
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.
@en
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.
@nl
prefLabel
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.
@en
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.
@nl
P2093
P1433
P1476
Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.
@en
P2093
Baldessarini RJ
P304
P356
10.1001/ARCHPSYC.1991.01810360046007
P407
P577
1991-12-01T00:00:00Z